Table 1.
Characteristics of baseline data for COVID-19-infected patients (n = 98).
| Age (year) | 43.0 ± 17.2 |
| Age group | |
| A (%) | 8 (8.2) |
| B (%) | 46 (46.9) |
| C (%) | 24 (24.5) |
| D (%) | 20 (20.4) |
| Time between first symptom and CT examination (days) | |
| A | 3.3 ± 3.8 |
| B | 4.2 ± 3.9 |
| C | 4.3 ± 4.1 |
| D | 4.2 ± 3.2 |
| Sex | |
| Female (%) | 52 (53.1) |
| Male (%) | 46 (46.9) |
| Clinical symptoms (%) | |
| Fever | 86 (87.8) |
| Fatigue or muscle soreness | 26 (26.5) |
| Dry cough | 64 (65.3) |
| Dyspnea | 3 (3.1) |
| Copious sputum | 0 (0) |
| Sore throat | 8 (8.2) |
| Direct or indirect exposure to people from Wuhan | 78 (79.6) |
| Laboratory analysis | |
| CRP (mg/h) (normal value, 0–10) | 24.1 ± 36.2 |
| SSA (mg/L) (normal value, 0–10) | 49.2 ± 43.0 |
| White blood cell count (normal value, 3–9.5 × 109/L) | 5.9 ± 2.5 × 109/L |
| Neutral particle count (normal value, 1.8–6.3 × 109/L) | 2.4 ± 2.7 × 109/L |
| Lymphocyte count (normal value, 1.1–3.0 × 109/L) | 1.7 ± 2.2 × 109/L |
Numbers listed on the right (in brackets) represent percentages.
Abbreviations: CRP, C-reactive protein; CT, computed tomography; SSA, serum amylase-like protein.